Evidence map›Paper›PMID 32332097›Full record

ArticleThe Journal of biological chemistry2020

Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.

Amel Dudakovic, Rebekah M Samsonraj, Christopher R Paradise, Catalina Galeano-Garces, Merel O Mol, Daniela Galeano-Garces, Pengfei Zan, M Lizeth Galvan, Mario Hevesi, Oksana Pichurin and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.Journal of cancer research and clinical oncology · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Amel DudakovicDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Rebekah M SamsonrajDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Christopher R ParadiseMayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-5882-709X
Catalina Galeano-GarcesDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-1882-6858
Merel O MolDepartment of Orthopedic Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Daniela Galeano-GarcesDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-0954-6352
Pengfei ZanDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
M Lizeth GalvanDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Mario HevesiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6208-878X
Oksana PichurinDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Roman ThalerDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Dana L BegunDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Peter KloenDepartment of Orthopedic Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Marcel KarperienDepartment of Developmental BioEngineering, University of Twente, Enschede, The Netherlands.
A Noelle LarsonDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-4464-6108
Simon M CoolGlycotherapeutics Group, Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA vanwijnen.andre@mayo.edu.ORCID 0000-0002-4458-0946
Mayo Clinic · USAmsterdam University Medical Centers · NLAgency for Science, Technology and Research · SGTongji University · CNUniversity of Twente · NL

Funding

Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
NIAMS NIH HHS R01 AR049069
6 · The paper itself

Abstract

Bone-stimulatory therapeutics include bone morphogenetic proteins (

Indexed as

3T3 CellsAnimalsBone Morphogenetic Protein 2Cell DifferentiationCells, CulturedEnhancer of Zeste Homolog 2 ProteinHumansIndolesMiceOsteoblastsOsteogenesisPyridonesBMP2 protein, humanBmp2 protein, mouseBone Morphogenetic Protein 2Enhancer of Zeste Homolog 2 ProteinGSK-2816126IndolesPyridonesBMP2bone developmentbone morphogenetic protein (BMP)chromatin regulationenhancer of zeste homologepigeneticsEzh2histone methylationmesenchymal stem cells (MSCs)methyltransferaseosteoblastosteogenesis

Identifiers

PMID32332097
PMCPMC7278362
OpenAlexW3017473147

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.